top of page
Acesion Pharma Announces Positive Results for Novel Drug Targeting Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
Nov 5, 20182 min read
Acesion Pharma Commences Phase 1 Study in Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
Mar 12, 20182 min read
Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
Feb 8, 20182 min read
LATEST NEWS
bottom of page